|
6567aa28212eaade2e0f33a6
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020018920
|
76_60046
|
3
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
2.200663
|
0
|
0
|
0
|
4.401326
|
0
|
|
|
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
50
|
AWARD TO PROVIDE HEALTH, NUTRI...TION, WASH, AND PROTECTION ASSISTANCE
more
|
Award to provide Health, Nutri...tion, WASH, and Protection assistance
more
|
Humanitarian Assistance - Awar...d to provide Health, Nutrition, WASH, and Protection assistance in Yemen
more
|
|
72050
|
Relief co-ordination and suppo...rt services
more
|
|
VIII.1. Emergency Response
|
21000
|
International NGO
|
NGO - International Redacted
|
|
|
|
6567aa28212eaade2e0f33a7
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020018921
|
76_60047
|
3
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
3.17838
|
0
|
0
|
0
|
6.35676
|
0
|
|
|
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
50
|
AWARD TO PROVIDE HEALTH, WASH,... AGFS, AND NUTRITION HUMANITARIAN SERVICES
more
|
Award to provide Health, WASH,... AgFS, and Nutrition humanitarian services
more
|
New 18 month award to provide ...Health, WASH, AgFS, and Nutrition humanitarian services in Yemen.
more
|
|
72050
|
Relief co-ordination and suppo...rt services
more
|
|
VIII.1. Emergency Response
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
6567aa28212eaade2e0f33a8
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019461
|
76_60795
|
3
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0
|
3.496943
|
0
|
0
|
0
|
3.496943
|
0
|
|
|
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
100
|
HEALTH HUMANITARIAN SERVICES
|
Health humanitarian services
|
Award to provide health humani...tarian services in Yemen.
more
|
|
72050
|
Relief co-ordination and suppo...rt services
more
|
|
VIII.1. Emergency Response
|
41307
|
World Health Organisation - as...sessed contributions
more
|
World Health Organisation - as...sessed contributions
more
|
|
|
|
6567aa28212eaade2e0f33a9
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019471
|
76_60806
|
1
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.13986786
|
1.0407243
|
0
|
0
|
0.211921
|
1.576855
|
0
|
0.211921
|
|
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
66
|
HEALTH, NUTRITION, AND WASH HU...MANITARIAN ASSISTANCE
more
|
Health, nutrition, and WASH hu...manitarian assistance
more
|
To provide health, nutrition, ...and WASH humanitarian assistance in Yemen.
more
|
|
72050
|
Relief co-ordination and suppo...rt services
more
|
|
VIII.1. Emergency Response
|
22000
|
Donor country-based NGO
|
NGO - Non United States Redact...ed
more
|
|
|
|
6567aa29212eaade2e0f33aa
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020020056
|
76_61642
|
3
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
3.9482348
|
0
|
0
|
0
|
9.870587
|
0
|
|
|
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
40
|
PROVIDE AG/FS, ERMS, NUTRITION..., WASH, AND HEALTH HUMANITARIAN ASSISTANCE
more
|
Provide AG/FS, ERMS, Nutrition..., WASH, and Health humanitarian assistance
more
|
Humanitarian Assistance - Prov...ide AG/FS, ERMS, Nutrition, WASH, and Health humanitarian assistance in Yemen.
more
|
|
72050
|
Relief co-ordination and suppo...rt services
more
|
|
VIII.1. Emergency Response
|
22000
|
Donor country-based NGO
|
Church and Faith Based - Unite...d States Redacted
more
|
|
|
|
6567aa29212eaade2e0f33ab
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020022919
|
76_64796
|
1
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
B03
|
15.84
|
0
|
0
|
0
|
24
|
0
|
0
|
24
|
|
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
66
|
HUMANITARIAN ASSISTANCE ACTIVI...TY - EMERGENCY HEALTH, WASH, NUTRITION IN YEMEN
more
|
Humanitarian Assistance Activi...ty - Emergency Health, WASH, Nutrition in Yemen
more
|
Emergency Health, WASH, Nutrit...ion in Yemen
more
|
|
72050
|
Relief co-ordination and suppo...rt services
more
|
|
VIII.1. Emergency Response
|
41000
|
United Nations (UN) agency, fu...nd or commission
more
|
Multilateral - United Nations ...Organization Redacted
more
|
|
|
|
6567aa29212eaade2e0f33ac
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020018013
|
76_58845
|
1
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-0.008947
|
|
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
25
|
LIFESAVING HEALTH, NUTRITION, ...PROTECTION, AND WASH SUPPORT TO CHILDREN AND FAMILIES
more
|
Lifesaving health, nutrition, ...protection, and WASH support to children and families
more
|
Lifesaving health, nutrition, ...protection, and WASH support to children and families
more
|
Huge
|
72050
|
Relief co-ordination and suppo...rt services
more
|
|
VIII.1. Emergency Response
|
41122
|
United Nations Children's Fund
|
United Nations Children's Fund
|
|
|
|
6567aa29212eaade2e0f33ad
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020020071
|
76_61672
|
1
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0.75
|
2.31996575
|
0
|
0
|
3
|
9.279863
|
0
|
3
|
|
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
25
|
PUBLIC INTERNATIONAL ORGANIZAT...ION GRANT FOR HUMANITARIAN ASSISTANCE
more
|
Public International Organizat...ion Grant for Humanitarian Assistance
more
|
To provide Health and Nutritio...n, WASH, Child Protection, and HCIM humanitarian assistance in Yemen.
more
|
no information found
|
72050
|
Relief co-ordination and suppo...rt services
more
|
|
VIII.1. Emergency Response
|
41122
|
United Nations Children's Fund
|
United Nations Children's Fund
|
|
|
|
6567aa29212eaade2e0f33ae
|
2014
|
United Kingdom
|
DFID
|
2013000097
|
200758-102
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0
|
52.6836
|
0
|
0
|
0
|
52.6836
|
0
|
0
|
|
|
Multilateral
|
AMFm
|
100
|
FUNDING FOR ANTI-MALARIAL TREA...TMENTS AS PILOT PROGRAMME IS INTEGRATED INTO GLOBAL FUND
more
|
Funding for Anti-Malarial trea...tments as pilot programme is integrated into Global Fund
more
|
Demonstrate whether the Afford...able Medicine Facilities for Medicine is an effective way to increase use of quality assured Artemisinin Combination Therapies, including by poor people and young children, and reduce the use of artemisinin monotherapies
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
44001
|
International Bank for Reconst...ruction and Development
more
|
International Bank for Reconst...ruction and Development
more
|
|
|
|
6567aa2a212eaade2e0f33af
|
2020
|
Austria
|
Federal Chancellery
|
2020078005
|
2020-0.374.051(b)
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0.45584
|
0.22792
|
0
|
0
|
0.45584
|
0.22792
|
0
|
0.45584
|
|
0
|
Multilateral
|
CEPI
|
100
|
CORE CONTRIBUTION FOR CEPI (10...0% ODA)
more
|
Core Contribution for CEPI (10...0% ODA)
more
|
Core Contribution for CEPI (10...0% ODA)
more
|
|
12250
|
Infectious disease control
|
3,17,16
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
CEPI
|
|
|
|
6567aa2a212eaade2e0f33b0
|
2020
|
Belgium
|
Directorate General for Co-ope...ration and Development
more
|
2020CO4591
|
3015
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
3.019943
|
3.019943
|
0
|
0
|
3.019943
|
3.019943
|
|
3.019943
|
|
0
|
Multilateral
|
CEPI
|
100
|
CORE CONTRIBUTION TO THE COALI...TION FOR EPIDEMIC PREPAREDNESS INNOVATIONS - CEPI , BOLSTERING EFFORTS TO MAKE A RELIABLE COVID-19 VACCIN AVAILABLE TO D
more
|
Core contribution to the Coali...tion for Epidemic Preparedness Innovations - CEPI , bolstering efforts to make a reliable Covid-19 vaccin available to d
more
|
|
0
|
12264
|
COVID-19 control
|
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations (CEPI
more
|
|
COVID-19
|
|
6567aa2b212eaade2e0f33b1
|
2020
|
Finland
|
Finnish Government
|
2020200803
|
99999906
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
1.139601
|
1.139601
|
0
|
0
|
1.139601
|
1.139601
|
|
1.139601
|
|
|
Multilateral
|
CEPI
|
100
|
CORE SUPPORT TO CEPI
|
Core support to CEPI
|
Core support to CEPI. Support ...through the Ministry of Social Affairs and Health.
more
|
CEPI
|
99810
|
Sectors not specified
|
|
IX. Unallocated / Unspecified
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations (CEPI)
more
|
|
|
|
6567aa2b212eaade2e0f33b2
|
2018
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2018013404
|
GG2017CEPI
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
27.5468
|
28.5781
|
0
|
0
|
27.5468
|
28.5781
|
0
|
27.5468
|
|
0
|
Multilateral
|
CEPI
|
100
|
COMMON DISEASES
|
Common diseases
|
Support for Coalition for Epid...emic Preparedness Innovations (CEPI) - Funding of multilateral institutions with a priority on promoting developing countries
more
|
Huge
Many organisations operat...e within the end-to-end space of vaccine funding and R&D implementation. However, a number of critical gaps have been identified, which CEPI was designed to fill.
First, CEPI will advance vaccines against known threats through proof-of-concept and safety testing in humans and will establish investigational vaccine stockpiles before epidemics begin—”just in case”.
Second, we will fund new and innovative platform technologies with the potential to accelerate the development and manufacture of vaccines against previously unknown pathogens (eg: within 16 weeks from identification of antigen to product release for clinical trials)—”just in time”.
Third, CEPI will support and coordinate activities to improve our collective response to epidemics, strengthen capacity in countries at risk, and advance the regulatory science that governs product development.
(Developing countries, unspecified GG2017CEPI Common diseases p.1)
more
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations (CEPI)
more
|
|
|
|
6567aa2b212eaade2e0f33b3
|
2019
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2019014762
|
GG2017CEPI
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
27.9861
|
0
|
0
|
0
|
27.9861
|
0
|
0
|
|
0
|
Multilateral
|
CEPI
|
100
|
COMMON DISEASES
|
Common diseases
|
Support for Coalition for Epid...emic Preparedness Innovations (CEPI) - Funding of multilateral institutions with a priority on promoting developing countries
more
|
Huge
Many organisations operat...e within the end-to-end space of vaccine funding and R&D implementation. However, a number of critical gaps have been identified, which CEPI was designed to fill.
First, CEPI will advance vaccines against known threats through proof-of-concept and safety testing in humans and will establish investigational vaccine stockpiles before epidemics begin—”just in case”.
Second, we will fund new and innovative platform technologies with the potential to accelerate the development and manufacture of vaccines against previously unknown pathogens (eg: within 16 weeks from identification of antigen to product release for clinical trials)—”just in time”.
Third, CEPI will support and coordinate activities to improve our collective response to epidemics, strengthen capacity in countries at risk, and advance the regulatory science that governs product development.
(Developing countries, unspecified GG2017CEPI Common diseases p.1)
more
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations (CEPI)
more
|
|
|
|
6567aa2b212eaade2e0f33b4
|
2017
|
Japan
|
Other Ministries
|
2017062601
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
2.5
|
2.5
|
0
|
0
|
2.5
|
2.5
|
0
|
2.5
|
|
|
Multilateral
|
CEPI
|
100
|
COALITION FOR EPIDEMIC PREPARE...DNESS INNOVATIONS
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
CEPI will incentivize the prod...uction of vaccines against epidemic diseases that disproportionately affect developing countries, by providing funding to support their development.
more
|
CEPI
|
12281
|
Health personnel development
|
|
I.2.b. Basic Health
|
31000
|
Public-Private Partnerships (P...PP)
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
|
|
6567aa2c212eaade2e0f33b5
|
2018
|
Japan
|
Other Ministries
|
2018050544
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
2.5
|
2.5
|
0
|
0
|
2.5
|
2.5
|
0
|
2.5
|
|
|
Multilateral
|
CEPI
|
100
|
COALITION FOR EPIDEMIC PREPARE...DNESS INNOVATION
more
|
Coalition for Epidemic Prepare...dness Innovation
more
|
CEPI will incentivize the prod...uction of vaccines against epidemic diseases that disproportionately affect developing countries, by providing funding to support their development.
more
|
CEPI
|
12281
|
Health personnel development
|
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
|
|
6567aa2c212eaade2e0f33b6
|
2019
|
Japan
|
Other Ministries
|
2019050523
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
2.5
|
2.5
|
0
|
0
|
2.5
|
2.5
|
0
|
2.5
|
|
|
Multilateral
|
CEPI
|
100
|
COALITION FOR EPIDEMIC PREPARE...DNESS INNOVATION
more
|
Coalition for Epidemic Prepare...dness Innovation
more
|
CEPI will incentivize the prod...uction of vaccines against epidemic diseases that disproportionately affect developing countries, by providing funding to support their development.
more
|
CEPI
|
12281
|
Health personnel development
|
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
|
|
6567aa2c212eaade2e0f33b7
|
2020
|
Japan
|
Other Ministries
|
2020050568
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
25.584545
|
25.584545
|
0
|
0
|
25.584545
|
25.584545
|
|
25.584545
|
|
|
Multilateral
|
CEPI
|
100
|
COALITION FOR EPIDEMIC PREPARE...DNESS INNOVATION
more
|
Coalition for Epidemic Prepare...dness Innovation
more
|
CEPI will incentivize the prod...uction of vaccines against epidemic diseases that disproportionately affect developing countries, by providing funding to support their development.
more
|
CEPI
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
COVID-19
|
|
6567aa2c212eaade2e0f33b8
|
2020
|
Japan
|
Other Ministries
|
2020050567
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
25.44
|
25.44
|
0
|
0
|
25.44
|
25.44
|
|
25.44
|
|
|
Multilateral
|
CEPI
|
100
|
COALITION FOR EPIDEMIC PREPARE...DNESS INNOVATION
more
|
Coalition for Epidemic Prepare...dness Innovation
more
|
CEPI will incentivize the prod...uction of vaccines against epidemic diseases that disproportionately affect developing countries, by providing funding to support their development.
more
|
CEPI
|
12264
|
COVID-19 control
|
3
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
COVID-19
|
|
6567aa2d212eaade2e0f33b9
|
2020
|
Japan
|
Other Ministries
|
2020050566
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
2.5
|
2.5
|
0
|
0
|
2.5
|
2.5
|
|
2.5
|
|
|
Multilateral
|
CEPI
|
100
|
COALITION FOR EPIDEMIC PREPARE...DNESS INNOVATION
more
|
Coalition for Epidemic Prepare...dness Innovation
more
|
CEPI will incentivize the prod...uction of vaccines against epidemic diseases that disproportionately affect developing countries, by providing funding to support their development.
more
|
CEPI
|
12281
|
Health personnel development
|
3
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
|
|
6567aa2d212eaade2e0f33ba
|
2020
|
Switzerland
|
Federal Administration (variou...s departments)
more
|
2020007814
|
046-2020-000004-Q46-2020-4
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
2.129925
|
2.129925
|
0
|
0
|
2.129925
|
2.129925
|
|
2.129925
|
|
|
Multilateral
|
CEPI
|
100
|
COALITION FOR EPIDEMIC PREPARE...DNESS INNOVATIONS (CEPI), CORE CONTRIBUTION
more
|
Coalition for Epidemic Prepare...dness Innovations (CEPI), core contribution
more
|
|
CEPI
|
12250
|
Infectious disease control
|
3.3
|
I.2.b. Basic Health
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
|
|
|
6567aa2d212eaade2e0f33bb
|
2020
|
United Kingdom
|
Department of Health and Soci...al Care
more
|
2020009743a
|
PDP_CEPI
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
11.06836
|
0
|
0
|
0
|
11.06836
|
0
|
0
|
|
|
Multilateral
|
CEPI
|
100
|
COALITION FOR EPIDEMIC PREPARE...DNESS INNOVATIONS (CEPI) - DEVELOPMENT OF VACCINES AGAINST DISEASES WITH EPIDEMIC POTENTIAL
more
|
Coalition for Epidemic Prepare...dness Innovations (CEPI) - Development of vaccines against diseases with epidemic potential
more
|
The Coalition for Epidemic Pre...paredness Innovations (CEPI) was formally launched at the World Economic Forum in Davos in January 2017. It is the only international alliance with a primary focus on developing vaccines for diseases with epidemic potential. CEPI's initial focus has been on developing vaccines against Lassa Fever, Nipah virus and Middle Eastern Respiratory Syndrome (MERS) virus. This research will be for the direct and primary benefit of countries on the OECD DAC-list.
more
|
|
12264
|
COVID-19 control
|
|
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
COVID-19
|
|
6567aa2e212eaade2e0f33bc
|
2020
|
United Kingdom
|
Department for International D...evelopment
more
|
2020000476b
|
204765-109
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
232.435552
|
0
|
0
|
0
|
232.435552
|
0
|
0
|
0
|
0
|
Multilateral
|
CEPI
|
100
|
CORE CONTRIBUTION TO THE COALI...TION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI) FOR COVID-19 VACCINE DEVELOPMENT
more
|
Core Contribution to the Coali...tion for Epidemic Preparedness Innovations (CEPI) for COVID-19 Vaccine Development
more
|
Epidemics and Global Health Se...curity Research Programme (Epidemics and GHS) - This programme will accelerate research and development for disease outbreaks (such as COVID19, Ebola etc) with the goal of preventing and tackling epidemics, saving lives and improving global health security. The programme will support the development of new vaccines, diagnostics and treatments for epidemic diseases and provide better evidence about outbreak diseases, to inform more effective preparedness and response activities.
more
|
CEPI
|
12264
|
COVID-19 control
|
|
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
COVID-19
|
|
6567aa2e212eaade2e0f33bd
|
2020
|
United Kingdom
|
Department of Health and Soci...al Care
more
|
2020009743b
|
PDP_CEPI
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
1.757086
|
0
|
0
|
0
|
1.757086
|
0
|
0
|
|
|
Multilateral
|
CEPI
|
100
|
COALITION FOR EPIDEMIC PREPARE...DNESS INNOVATIONS (CEPI) - DEVELOPMENT OF VACCINES AGAINST DISEASES WITH EPIDEMIC POTENTIAL
more
|
Coalition for Epidemic Prepare...dness Innovations (CEPI) - Development of vaccines against diseases with epidemic potential
more
|
The Coalition for Epidemic Pre...paredness Innovations (CEPI) was formally launched at the World Economic Forum in Davos in January 2017. It is the only international alliance with a primary focus on developing vaccines for diseases with epidemic potential. CEPI's initial focus has been on developing vaccines against Lassa Fever, Nipah virus and Middle Eastern Respiratory Syndrome (MERS) virus. This research will be for the direct and primary benefit of countries on the OECD DAC-list.
more
|
|
12182
|
Medical research
|
|
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
|
|
6567aa2e212eaade2e0f33be
|
2020
|
United Kingdom
|
Department for International D...evelopment
more
|
2020000476a
|
204765-109
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
269.334359
|
36.898807
|
0
|
0
|
269.334359
|
36.898807
|
0
|
269.334359
|
0
|
0
|
Multilateral
|
CEPI
|
100
|
CORE CONTRIBUTION TO THE COALI...TION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI)
more
|
Core Contribution to the Coali...tion for Epidemic Preparedness Innovations (CEPI)
more
|
Epidemics and Global Health Se...curity Research Programme (Epidemics and GHS) - This programme will accelerate research and development for disease outbreaks (such as COVID19, Ebola etc) with the goal of preventing and tackling epidemics, saving lives and improving global health security. The programme will support the development of new vaccines, diagnostics and treatments for epidemic diseases and provide better evidence about outbreak diseases, to inform more effective preparedness and response activities.
more
|
CEPI
|
12182
|
Medical research
|
|
|
31006
|
Coalition for Epidemic Prepare...dness Innovations
more
|
Coalition for Epidemic Prepare...dness Innovations
more
|
|
|
|
6567aa2e212eaade2e0f33bf
|
2020
|
Italy
|
Ministry of Economy and Financ...e
more
|
2020130025
|
DT202019
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
3.019943
|
3.019943
|
0
|
0
|
3.019943
|
3.019943
|
|
3.019943
|
0
|
0
|
Multilateral
|
CEPI-IFFIm
|
100
|
CONTRIBUTION TO IFFIM FOR CEPI... PROGRAMS (53% ODA)
more
|
contribution to IFFIm for CEPI... programs (53% ODA)
more
|
contribution to CEPI through I...FFIm (53% ODA eligibile) for COVID-19 vaccines R&D, as per 2020 agreement
more
|
|
12264
|
COVID-19 control
|
3.b
|
I.2.b. Basic Health
|
47107
|
International Finance Facility... for Immunisation
more
|
IFFIm
|
|
COVID-19
|
|
6567aa2e212eaade2e0f33c0
|
2020
|
Spain
|
Comunidad Autónoma del País ...Vasco o de Euskadi
more
|
2020000537-1
|
009-135583-A
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.22792
|
0.22792
|
0
|
0
|
0.22792
|
0.22792
|
0
|
0.22792
|
0
|
0
|
Multilateral
|
CERF
|
100
|
DIRECT SUBSIDY FOR THE CENTRAL... EMERGENCY RESPONSE FUND OF UNITED NATIONS (CERF)
more
|
Direct subsidy for the central... emergency response fund of United Nations (CERF)
more
|
El objeto de esta subvención ...es financiar actuaciones de respuesta rápida a fin de salvar vidas en tiempos críticos (mecanismo de respuesta rápida), así como responder a las necesidades humanitarias de emergencias sub-financiadas (mecanismo de financiación insuficiente). Las prioridades las establecerá el Coordinador Residente/Humanitario del país afectado por la crisis humanitaria.
more
|
|
72010
|
Material relief assistance and... services
more
|
1.5
|
VIII.1. Emergency Response
|
41147
|
Central Emergency Response Fun...d
more
|
Central Emergency Response Fun...d
more
|
|
|
|
6567aa2e212eaade2e0f33c1
|
2015
|
Netherlands
|
MFA
|
2011000623
|
23383
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.775189
|
0
|
0
|
0
|
0.775189
|
0
|
0
|
0
|
0
|
Multilateral
|
DNDi
|
100
|
DSO PDPNEGLECTED DISEASES DNDI
|
DSO PDPneglected diseases DNDi
|
PDP subsidie DNDi 2001 t/m 201...4
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
DNDI
|
|
|
|
6567aa2f212eaade2e0f33c2
|
2014
|
Switzerland
|
SDC
|
2010004633
|
7F-07741.01-22000-998-12250-B0...1
more
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
0.196721
|
0
|
0
|
0
|
0.196721
|
0
|
0
|
0
|
0
|
Multilateral
|
DNDi
|
100
|
DNDI DRUGS FOR DISEASES OF POV...ERTY
more
|
DNDi Drugs for diseases of pov...erty
more
|
Global Organisation (GO) - Dru...gs for Neglected Diseases initiative (DNDi). Tasks of the GO and its role in the aid architecture: DNDi is the only global NGO that focuses on neglected diseases. In close colaboration with pharma industries, academics and research institutes in countries, DNDi developps new treatments for 3 neglected diseases (HAT, VL, Chagas) en developing endemic countries. DNDi areas of works covers the three pillars of SDC health strategy: 1) health system strengthening; 2) maternal and child health; 3) fight against communicable diseases.
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
22000
|
National NGOs
|
|
|
|
|
6567aa2f212eaade2e0f33c3
|
2016
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2010004468
|
7F-07741.02-22000-998-12250-B0...1
more
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
2.03025
|
0
|
0
|
0
|
2.03025
|
0
|
0
|
0
|
0
|
Multilateral
|
DNDi
|
100
|
FIGHTING DISEASES OF POVERTY: ...DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI)
more
|
Fighting diseases of poverty: ...Drugs for Neglected Diseases Initiative (DNDi)
more
|
As one of the leading Product ...Development Partnerships (PDPs) worldwide, DNDi is acting in the public interest and to respond to patients' needs to develop and provide access to treatments for neglected tropical diseases that primarily affect the poor and marginalised populations worldwide. DNDi's business model is further characterized by empowerment of endemic country partners, international advocacy in support of a global framework for essential health, and delivery of health tools as public goods.
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
22000
|
National NGOs
|
|
|
|
|
6567aa2f212eaade2e0f33c4
|
2020
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2010005747
|
7F-07741.03.01
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
1.490948
|
0
|
0
|
|
1.490948
|
|
|
|
|
Multilateral
|
DNDi
|
100
|
FIGHTING DISEASES OF POVERTY:D...RUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI)
more
|
Fighting diseases of poverty:D...rugs for Neglected Diseases Initiative (DNDi)
more
|
Neglected tropical diseases ma...inly affect poor and marginalised populations in low and middle-income countries who have no purchasing power. This is the main reason why there is no incentive for the private sector to develop appropriate treatments for these diseases. DNDi develops and provides worldwide access to new and improved treatments as well as contributes to strengthening research capacities in endemic countries and advocates research on these diseases.
more
|
0
|
12250
|
Infectious disease control
|
3.8,3.3
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
|
|
|
|
6567aa31212eaade2e0f33c5
|
2020
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2010005974
|
7F-07741.04.01
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
5.963791
|
0
|
0
|
0
|
5.963791
|
|
|
5.963791
|
|
|
Multilateral
|
DNDi
|
100
|
FIGHTING DISEASES OF POVERTY:D...RUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI)
more
|
Fighting diseases of poverty:D...rugs for Neglected Diseases Initiative (DNDi)
more
|
Neglected tropical diseases ma...inly affect poor and marginalised populations in low and middle-income countries who have no purchasing power. This is the main reason why there is no incentive for the private sector to develop appropriate treatments for these diseases. The private-public partnership Drug for Neglected Disease initiative based in Geneva develops and provides worldwide access to new and improved treatments. Swiss research contributes to these efforts.
more
|
0
|
12250
|
Infectious disease control
|
3.8,3.3,16,10.2
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
|
|
|
|
6567aa31212eaade2e0f33c6
|
2015
|
United Kingdom
|
DFID
|
2013001188
|
204075-101
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
13.751
|
0
|
0
|
0
|
13.751
|
0
|
0
|
|
|
Multilateral
|
DNDi
|
100
|
TO FUND THE DEVELOPMENT OF NEW... EFFECTIVE TREATMENTS FOR NEGLECTED DISEASES THROUGH THE ORGANISATION DRUGS FOR NEGLECTED DISEASES INITIATIVE.
more
|
To fund the development of new... effective treatments for neglected diseases through the organisation Drugs for Neglected Diseases initiative.
more
|
This investment will contribut...e towards the ultimate goal of achieving the World Health Organisation 2020 Neglected Tropical Disease (NTD) control and elimination targets through the development of, and increased access to, affordable and appropriate new
more
|
The additional funding will be... used to support a number of urgently required activities during 2015, in line with the expected outputs in the existing business case. The detailed expected results include:
Sleeping sickness:
Additional Clinical studies in the Democratic Republic of Congo to test the new drug fexinidazole in a pivotal phase II‐III study. Additional clinical studies with fexinidazole in early stage patients (FEX 005) and with children (FEX 006), including monitoring and maintenance of the clinical sites. New clinical study on fexinidazole for sleeping sickness Tb Rhodesiense (FEXI007), preparation of two sites in two countries (Malawi and Uganda).
Visceral and Cutaneous leishmaniasis:
Preparation of the sites in India and Bangladesh for an open label, randomised, non‐comparative phase II clinical trial measuring safety and efficacy of two treatment regimens. Screen 2 private sector company compound libraries (over 2.3 million compounds) to identify an estimated 10-15 active leads. Active Pharmaceutical Ingredient development and good manufacturing practice formulation, development, and clinical supplies. Start clinical study in Peru and Colombia using a single thermotherapy using a short course (3 weeks) of oral miltefosine compared to a single thermotherapy application administered with a placebo.
Chagas Disease:
Carry forward part of the 12 month follow up of the phase II study of fexinidazole as a monotherapy for Chagas patients with indeterminate chronic disease. Continuation of the study performed along with the University of Georgia (USA) to assess potential biomarkers of treatment response to enhance clinical trial capabilities for evaluation of new compounds.
Mycetoma:
Carry forward Preparation phase for the clinical study starting in 2016, to include protocol writing/submission, site visit, negotiations with partners, etc. Packaging and clinical supplies in preparation for the future.
Filarial:
Carry forward urgently needed filarial discovery work, including consultations to shape the platform, organisation of meetings and travel.
(Developing countries, unspecified 204075-101 To fund the development of new effective treatments for neglected diseases p.1-2)
more
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
22000
|
National NGOs
|
Donor country-based NGO
|
|
|
|
6567aa32212eaade2e0f33c7
|
2018
|
United Kingdom
|
Department for International D...evelopment
more
|
2018006092
|
300341-103
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
20.8208
|
0
|
0
|
0
|
20.8208
|
0
|
|
|
|
Multilateral
|
DNDi
|
100
|
DRUGS FOR NEGLECTED DISEASES I...NITIATIVE (DNDI) 2017-2021 FOR THE DEVELOPMENT OF NEW EFFECTIVE TREATMENTS FOR NEGLECTED DISEASES AND DISEASES WITH EME
more
|
Drugs for Neglected Diseases i...nitiative (DNDi) 2017-2021 for the development of new effective treatments for neglected diseases and diseases with eme
more
|
This programme in the Ross Fun...d Portfolio (which focusses on neglected tropical diseases, diseases of emerging resistance and diseases of epidemic potential) will support the development of new products (such as drugs, diagnostics and insecticides) for targeted diseases, including diseases of emerging resistance (that are becoming an increasing threat globally); neglected tropical diseases (that affect over a billion people worldwide); and diseases of epidemic potential (that can rapidly spread if not stopped).
more
|
NTDs
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
22000
|
Donor country-based NGO
|
Donor country-based NGO
|
|
|
|
6567aa32212eaade2e0f33c8
|
2020
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2013006258
|
7F-08866.02.01
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
0.879659
|
0
|
0
|
|
0.879659
|
|
|
|
|
Multilateral
|
FIND
|
100
|
FOUNDATION FOR INNOVATIVE NEW ...DIAGNOSTICS FIND
more
|
Foundation for Innovative New ...Diagnostics FIND
more
|
The Foundation for Innovative ...New Diagnostics (FIND), working through a public-private partnership model, drives the development and early implementation of new diagnostic tests for poverty-related diseases. From a global public health perspective, accurate and affordable diagnosis is critical. It helps ensure better care to patients, enables equitable, timely and correct medical treatment in low-resource settings, and thus reduces wastage of medicines and antimicrobial resistance. It is essential also for emergency preparedness.
more
|
0
|
12250
|
Infectious disease control
|
3.8,3.3
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
|
|
|
|
6567aa34212eaade2e0f33c9
|
2020
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2013006693
|
7F-08866.02.11
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0.074547
|
0
|
0
|
0
|
0.074547
|
|
|
0.074547
|
|
|
Multilateral
|
FIND
|
100
|
FOUNDATION FOR INNOVATIVE NEW ...DIAGNOSTICS FIND
more
|
Foundation for Innovative New ...Diagnostics FIND
more
|
The Foundation for Innovative ...New Diagnostics (FIND), working through a public-private partnership model, drives the development and early implementation of new diagnostic tests for poverty-related diseases. From a global public health perspective, accurate and affordable diagnosis is critical. It helps ensure better care to patients, enables equitable, timely and correct medical treatment in low-resource settings, and thus reduces wastage of medicines and antimicrobial resistance. It is essential also for emergency preparedness.
more
|
0
|
12250
|
Infectious disease control
|
3.8,3.3
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
|
|
COVID-19
|
|
6567aa34212eaade2e0f33ca
|
2020
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2013006692
|
7F-08866.02.02
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0.047923
|
0
|
0
|
0
|
0.047923
|
|
|
0.047923
|
|
|
Multilateral
|
FIND
|
100
|
FOUNDATION FOR INNOVATIVE NEW ...DIAGNOSTICS FIND
more
|
Foundation for Innovative New ...Diagnostics FIND
more
|
The Foundation for Innovative ...New Diagnostics (FIND), working through a public-private partnership model, drives the development and early implementation of new diagnostic tests for poverty-related diseases. From a global public health perspective, accurate and affordable diagnosis is critical. It helps ensure better care to patients, enables equitable, timely and correct medical treatment in low-resource settings, and thus reduces wastage of medicines and antimicrobial resistance. It is essential also for emergency preparedness.
more
|
0
|
99810
|
Sectors not specified
|
3.8,3.3,1.a
|
IX. Unallocated / Unspecified
|
22000
|
Donor country-based NGO
|
|
|
|
|
6567aa35212eaade2e0f33cb
|
2015
|
United Kingdom
|
DFID
|
2013001187
|
204074-101
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
3.05577
|
0
|
0
|
0
|
3.05577
|
0
|
0
|
|
|
Multilateral
|
FIND
|
100
|
TO FUND THE DEVELOPMENT OF NEW... DIAGNOSTIC TESTING FOR NEGLECTED DISEASES THROUGH THE ORGANISATION FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS.
more
|
To fund the development of new... diagnostic testing for neglected diseases through the organisation Foundation for Innovative New Diagnostics.
more
|
To research and develop new di...agnostic tests for the neglected diseases of the poor, including Tuberculosis, Sleeping Sickness, Leishmaniasis, Malaria and Non-malarial febrile illness, through public private partnership. This research will advance the dev
more
|
Working to accelerate diagnost...ics development across TB, sleeping sickness, leishmaniasis, malaria and non-malarial febrile illness, and potentially in new disease areas, the main 5-year outputs associated with this funding are:
• 5+ neglected disease diagnostic tests developed and in use in disease endemic countries
• Strong and balanced pipeline of diagnostics in development, including 3-5 fully evaluated tests and another 4-6 for which technical feasibility has been established
• Strategic portfolio expansion into at least 1 new disease area
(Developing countries, unspecified 204074 To fund the development of new diagnostic testing for neglected diseases p.2)
more
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
22000
|
National NGOs
|
Donor country-based NGO
|
|
|
|
6567aa36212eaade2e0f33cc
|
2020
|
United Kingdom
|
Department for International D...evelopment
more
|
2017000709a
|
300341-102
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
29.498525
|
0
|
0
|
0
|
29.498525
|
0
|
0
|
|
|
Multilateral
|
FIND
|
100
|
FOUNDATION FOR INNOVATIVE NEW ...DIAGNOSTICS (FIND) 2017-2021FOR THE DEVELOPMENT OF NEW DIAGNOSTIC TESTING FOR EPIDEMIC DISEASES, DISEASES WITH EMERGING
more
|
Foundation for Innovative New ...Diagnostics (FIND) 2017-2021for the development of new diagnostic testing for epidemic diseases, diseases with emerging
more
|
This programme in the Ross Fun...d Portfolio (which focusses on neglected tropical diseases, diseases of emerging resistance and diseases of epidemic potential) will support the development of new products (such as drugs, diagnostics and insecticides) for targeted diseases, including diseases of emerging resistance (that are becoming an increasing threat globally), neglected tropical diseases (that affect over a billion people worldwide), and diseases of epidemic potential (that can rapidly spread if not stopped).
more
|
0
|
12182
|
Medical research
|
|
|
22000
|
Donor country-based NGO
|
Donor country-based NGO
|
|
COVID-19
|
|
6567aa36212eaade2e0f33cd
|
2020
|
United Kingdom
|
Department for International D...evelopment
more
|
2017000709b
|
300341-102
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
11.285731
|
0
|
0
|
0
|
11.285731
|
0
|
0
|
|
|
Multilateral
|
FIND
|
100
|
FOUNDATION FOR INNOVATIVE NEW ...DIAGNOSTICS (FIND) 2017-2021FOR THE DEVELOPMENT OF NEW DIAGNOSTIC TESTING FOR EPIDEMIC DISEASES, DISEASES WITH EMERGING
more
|
Foundation for Innovative New ...Diagnostics (FIND) 2017-2021for the development of new diagnostic testing for epidemic diseases, diseases with emerging
more
|
This programme in the Ross Fun...d Portfolio (which focusses on neglected tropical diseases, diseases of emerging resistance and diseases of epidemic potential) will support the development of new products (such as drugs, diagnostics and insecticides) for targeted diseases, including diseases of emerging resistance (that are becoming an increasing threat globally), neglected tropical diseases (that affect over a billion people worldwide), and diseases of epidemic potential (that can rapidly spread if not stopped).
more
|
0
|
12182
|
Medical research
|
|
|
22000
|
Donor country-based NGO
|
Donor country-based NGO
|
|
|
|
6567aa36212eaade2e0f33ce
|
2018
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2018008046
|
177-Q37-2017-4951
|
3
|
El Salvador
|
North & Central America
|
LMICs
|
ODA Grants
|
7
|
10
|
110
|
B01
|
0
|
0.0556253
|
0
|
0
|
0
|
0.0556253
|
0
|
0
|
0
|
0
|
Classified as not health-speci...fic activity
more
|
|
100
|
CONTRIBUTIONS DE PROGRAMME AUX... ONG SUISSES
more
|
Contributions de programme aux... ONG suisses
more
|
Par son programme « travail e...n dignité », Brücke-Le pont s'engage dans la formation professionnelle, l'accès au marché du travail, la création de revenus et pour le respect des droits du travail. Brücke-Le pont renforce les réseaux locaux qui se mobilisent pour mettre en place des réformes juridiques et structurelles. L'organisation promeut l'égalité entre hommes et femmes, l'autodétermination des personnes et le renforcement institutionnel des organisations partenaires.
more
|
Based on information regarding... focus areas of specific implementing organization
more
|
99810
|
Sectors not specified
|
|
IX. Unallocated / Unspecified
|
22000
|
Donor country-based NGO
|
Brücke-Le Pont (anc. Brücke ...Cecotret)
more
|
|
|
|
6567aa36212eaade2e0f33cf
|
2015
|
United Kingdom
|
DFID
|
2013001191
|
204086-101
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
10.6952
|
0
|
0
|
0
|
10.6952
|
0
|
0
|
|
|
Multilateral
|
GATB
|
100
|
TO FUND THE DEVELOPMENT OF NEW..., SAFE AND EFFECTIVE DRUGS FOR TUBERCULOSIS THROUGH THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT ORGANISATION.
more
|
To fund the development of new..., safe and effective drugs for tuberculosis through the Global Alliance for TB Drug Development organisation.
more
|
To research and develop new dr...ugs for the treatment of tuberculosis (TB) through public private partnership. This research will advance the development of new, easier to use, and cheaper drugs for the treatment of TB, multi-drug resistant TB and extremely
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
21000
|
International NGOs
|
INTERNATIONAL NGO
|
|
|
|
6567aa37212eaade2e0f33d0
|
2015
|
United States
|
AID
|
2015013486
|
76_47458
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
4
|
4
|
0
|
0
|
4
|
4
|
0
|
4
|
0
|
0
|
Multilateral
|
GATB
|
100
|
CORE FUNDS TO GLOBAL ALLIANCE ...FOR TB DRUG DEVELOPMENT - TUBERCULOSIS
more
|
Core funds to Global Alliance ...for TB Drug Development - Tuberculosis
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
National NGOs
|
Global Alliance for TB Drug De...velopment
more
|
|
|
|
6567aa38212eaade2e0f33d1
|
2016
|
United States
|
Agency for International Devel...opment
more
|
2016016488
|
76_36710
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
Multilateral
|
GATB
|
100
|
CORE FUNDS TO GLOBAL ALLIANCE ...FOR TB DRUG DEVELOPMENT - HIV/AIDS
more
|
Core funds to Global Alliance ...for TB Drug Development - HIV/AIDS
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
|
13040
|
Std control including hiv/aids
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
National NGOs
|
Global Alliance for TB Drug De...velopment
more
|
|
|
|
6567aa38212eaade2e0f33d2
|
2016
|
United States
|
Agency for International Devel...opment
more
|
2016016489
|
76_36710
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
6.2
|
4
|
0
|
0
|
6.2
|
4
|
0
|
6.2
|
0
|
0
|
Multilateral
|
GATB
|
100
|
CORE FUNDS TO GLOBAL ALLIANCE ...FOR TB DRUG DEVELOPMENT - TUBERCULOSIS
more
|
Core funds to Global Alliance ...for TB Drug Development - Tuberculosis
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
National NGOs
|
Global Alliance for TB Drug De...velopment
more
|
|
|
|
6567aa38212eaade2e0f33d3
|
2017
|
United States
|
Agency for International Devel...opment
more
|
2017015676B
|
76_37505
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
2.2
|
0
|
0
|
0
|
2.2
|
0
|
0
|
0
|
0
|
Multilateral
|
GATB
|
100
|
CORE FUNDS TO GLOBAL ALLIANCE ...FOR TB DRUG DEVELOPMENT
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
National NGOs
|
Global Alliance for TB Drug De...velopment
more
|
|
|
|
6567aa38212eaade2e0f33d4
|
2017
|
United States
|
Agency for International Devel...opment
more
|
2017015676A
|
76_37505
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
3.5
|
0
|
0
|
0
|
3.5
|
0
|
0
|
3.5
|
|
|
Multilateral
|
GATB
|
100
|
CORE FUNDS TO GLOBAL ALLIANCE ...FOR TB DRUG DEVELOPMENT
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
National NGOs
|
Global Alliance for TB Drug De...velopment
more
|
|
|
|
6567aa38212eaade2e0f33d5
|
2017
|
United States
|
Agency for International Devel...opment
more
|
2017015676C
|
76_37505
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
Multilateral
|
GATB
|
100
|
CORE FUNDS TO GLOBAL ALLIANCE ...FOR TB DRUG DEVELOPMENT
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
|
13040
|
STD control including HIV/AIDS
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
National NGOs
|
Global Alliance for TB Drug De...velopment
more
|
|
|
|
6567aa38212eaade2e0f33d6
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018011788A
|
76_37735
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.95
|
3.5
|
0
|
0
|
1.95
|
3.5
|
0
|
1.95
|
0
|
0
|
Multilateral
|
GATB
|
100
|
CORE FUNDS TO GLOBAL ALLIANCE ...FOR TB DRUG DEVELOPMENT
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Global Alliance for TB Drug De...velopment
more
|
|
|
|
6567aa39212eaade2e0f33d7
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018011788B
|
76_37735
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Multilateral
|
GATB
|
100
|
CORE FUNDS TO GLOBAL ALLIANCE ...FOR TB DRUG DEVELOPMENT
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
Core funds to Global Alliance ...for TB Drug Development
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Global Alliance for TB Drug De...velopment
more
|
|
|
